The cost-effectiveness of low-dose budesonide as a Step 2 treatment for pediatric asthma in China.

Conclusion: These findings may improve the use of low-dose budesonide, an economically and clinically preferable treatment to montelukast in pediatric patients. PMID: 33153279 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research